Financial Performance - Shanghai Chicmax Cosmetic Co., Ltd. reported a revenue of RMB 9,177.8 million for the year ending December 31, 2025, representing a 35.1% increase from RMB 6,792.5 million in 2024[4] - The gross profit for the same period was RMB 7,014.7 million, up 37.3% from RMB 5,109.4 million in 2024[4] - The net profit for 2025 was RMB 1,154.2 million, reflecting a 43.7% increase compared to RMB 803.3 million in 2024[4] - Revenue increased from RMB 6,792.5 million in 2024 to RMB 9,177.8 million in 2025, representing a growth of 35.1%[32] - The net profit for 2025 was RMB 1,154.2 million, a 43.7% increase from RMB 803.3 million in 2024[57] - Basic earnings per share for 2025 is RMB 2.77, up from RMB 1.96 in 2024, representing an increase of approximately 41.3%[77] Brand Performance - The brand Han Shu generated revenue of RMB 7,359.6 million in 2025, a 31.6% increase year-over-year, accounting for 80.2% of the total annual revenue[9] - Han Shu's online channel GMV ranked first among domestic beauty brands in 2025[8] - The brand achieved the highest online sales in the Chinese children's cream sector and ranked first in the high-end baby oil category, as certified by iResearch Consulting[12] - The brand's children's makeup series was recognized as the top online seller in China by Sullivan[16] - The skincare brand 韩束 generated revenue of RMB 7,359.6 million in 2025, up 31.6% from RMB 5,591.0 million in 2024[35] - The brand newpage saw a significant revenue increase of 134.2%, from RMB 375.6 million in 2024 to RMB 879.6 million in 2025[35] Research and Development - The company invested RMB 224.7 million in R&D in 2025, a 24.9% increase from RMB 179.9 million in 2024[19] - The company published 10 research papers in 2025, covering areas such as peptide anti-aging and skin repair, contributing to a comprehensive research system[21] - The company applied for 61 new patents in 2025, including 33 invention patents, and was granted 49 new patents, with 9 being invention patents[20] - The company plans to enhance its research and development investments, focusing on core ingredients in skincare, including anti-aging technology and skin barrier repair technology[30] - Research and development costs increased by 24.9% from RMB 179.9 million in 2024 to RMB 224.7 million in 2025, reflecting increased R&D activities[44] Marketing and Expansion - The company plans to continue expanding its product lines, including the launch of new products in the peptide skincare category and the introduction of a new makeup series[8][9] - The company is committed to expanding its marketing network, particularly enhancing its presence on e-commerce platforms such as Douyin, Tmall, Taobao, and JD[30] - The company has established two multinational research centers and two supply chain bases globally to support its multi-brand strategy[6] - The company has initiated a large-scale empirical study on cosmetic consumption behavior among children aged 0-12, filling a significant gap in local children's skin exposure science[25] Financial Position and Cash Flow - Operating cash flow for 2025 was approximately RMB 1,205.2 million, up from RMB 547.0 million in 2024, marking a 120% increase[51] - The company's cash and cash equivalents as of December 31, 2025, were approximately RMB 802.3 million, compared to RMB 459.4 million in 2024, reflecting a 74.6% increase[51] - Interest-bearing bank borrowings rose by 382.7% to RMB 290.1 million in 2025 from RMB 60.1 million in 2024, primarily due to business expansion[52] - The company's asset-liability ratio increased to 42.1% in 2025 from 37.9% in 2024[51] - Non-current assets increased to RMB 1,805,376 thousand in 2025, up 60.0% from RMB 1,125,757 thousand in 2024[60] Employee and Operational Expenses - The company achieved a total salary cost of RMB 969.3 million in 2025, up from RMB 551.3 million in 2024, reflecting a significant increase in employee compensation[23] - Administrative expenses grew by 32.0% from RMB 242.8 million in 2024 to RMB 320.5 million in 2025[43] - Sales and distribution expenses increased by 35.9% from RMB 3,947.3 million in 2024 to RMB 5,362.7 million in 2025[42] - The company reported a significant increase in employee benefits expenses, totaling RMB 835,310 thousand in 2025, compared to RMB 552,021 thousand in 2024[72] Corporate Governance and Compliance - The company aims to enhance corporate governance practices in line with the new corporate governance code effective from July 1, 2025[85] - The audit committee has reviewed the consolidated annual results for the year ending December 31, 2025, confirming compliance with applicable accounting standards and regulations[94] Dividend and Shareholder Returns - The board proposed a final dividend of RMB 0.75 per share for the year ending December 31, 2025, consistent with the previous year's dividend[5] - Proposed final dividend for 2025 is RMB 0.75 per share, unchanged from 2024, with total dividends amounting to RMB 497,572,000[78] Use of Proceeds from Offerings - The net proceeds from the global offering amount to approximately HKD 859.7 million, which will be utilized as per the planned schedule[90] - Brand building activities accounted for 32% of the total proceeds, amounting to HKD 275.5 million, with a focus on enhancing brand image and recognition[96] - Research and development capabilities were strengthened with 12.2% of the proceeds, totaling HKD 104.9 million, aimed at continuous innovation[96] - Production and supply chain capabilities were enhanced with 19.8% of the proceeds, amounting to HKD 170.6 million, primarily through factory upgrades and capacity expansion[96] - The sales network expansion accounted for 18% of the proceeds, totaling HKD 154.5 million, to improve product penetration[96]
上美股份(02145) - 2025 - 年度业绩